Algernon NeuroScience Announces Successful Completion of Highest Planned Single Dose in...

Psychedelics Weekly – Drug Testing and Harm Reduction, Ketamine vs. ECT,...

Terran Biosciences announces exclusive licensing deal with Pierre Fabre for idazoxan;...

Silo Pharma Announces Participation on Webull Corporate Communications Service Platform

Numinus to Participate in a Water Tower Research Fireside Chat on...

atai Life Sciences to Participate in Upcoming June Investor Conferences

Reunion Neuroscience Announces US$13.1 Million Take-Private Transaction with MPM BioImpact

BREAKING: State of Kentucky Sets aside $42 Million for Psychedelic Research,...

Algernon Pharmaceuticals Receives Notice of Allowance from the Japanese Patent Office...

COMPASS Pathways’ Co-Founder Ekaterina Malievskaia to Step Down as Chief Innovation...

Load more